Retnakaran Ravi, Qi Ying, Sermer Mathew, Connelly Philip W, Zinman Bernard, Hanley Anthony J G
Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada.
Diabetes Care. 2008 Jul;31(7):1275-81. doi: 10.2337/dc08-0126. Epub 2008 Mar 20.
Gestational impaired glucose tolerance (GIGT), defined by a single abnormal value on antepartum 3-h oral glucose tolerance test (OGTT), is a metabolically heterogeneous disorder. Indeed, the antepartum metabolic phenotype of women with a single abnormal value at 1 h during the OGTT (1-h GIGT) resembles that of women with gestational diabetes mellitus (GDM), whereas GIGT at 2 or 3 h (2/3-h GIGT) is similar to normal glucose tolerance (NGT). Thus, we hypothesized that 1-h GIGT would be associated with the same adverse outcomes as GDM, i.e., increased infant birth weight and postpartum metabolic dysfunction.
A total of 361 women underwent an antepartum glucose challenge test (GCT) and a 3-h OGTT, assessment of obstetrical outcome at delivery, and metabolic characterization by OGTT at 3 months postpartum. The antepartum GCT/OGTT identified five study groups: GDM (n = 97), 1-h GIGT (n = 28), 2/3-h GIGT (n = 34), abnormal GCT NGT (abnormal GCT with NGT on OGTT) (n = 128), and normal GCT NGT (normal GCT with NGT on OGTT) (n = 74).
Caesarian section rate was higher in women with 1-h GIGT, but birth weight did not differ significantly between the non-GDM groups (P = 0.1978). At 3 months postpartum, glycemia (area under the glucose curve) progressively increased across the groups from normal GCT NGT to abnormal GCT NGT to 2/3-h GIGT to 1-h GIGT to GDM (P < 0.0001), while both insulin sensitivity (IS(OGTT)) and beta-cell function (insulinogenic index/homeostasis model assessment of insulin resistance [HOMA-IR]) progressively decreased (P = 0.002 and P < 0.0001, respectively). The strongest independent negative predictors of insulinogenic index/HOMA-IR were GDM (t = -4.1, P < 0.0001) and 1-h GIGT (t = -3.8, P = 0.0002).
Like GDM, 1-h GIGT is associated with postpartum glycemia, insulin resistance, and beta-cell dysfunction.
妊娠期糖耐量受损(GIGT)由产前3小时口服葡萄糖耐量试验(OGTT)中的单个异常值定义,是一种代谢异质性疾病。实际上,在OGTT期间1小时出现单个异常值的女性(1小时GIGT)的产前代谢表型类似于妊娠期糖尿病(GDM)女性,而2或3小时的GIGT(2/3小时GIGT)与正常糖耐量(NGT)相似。因此,我们假设1小时GIGT与GDM具有相同的不良结局,即婴儿出生体重增加和产后代谢功能障碍。
共有361名女性接受了产前葡萄糖筛查试验(GCT)和3小时OGTT,评估分娩时的产科结局,并在产后3个月通过OGTT进行代谢特征分析。产前GCT/OGTT确定了五个研究组:GDM(n = 97)、1小时GIGT(n = 28)、2/3小时GIGT(n = 34)、异常GCT NGT(OGTT为NGT但GCT异常)(n = 128)和正常GCT NGT(OGTT为NGT且GCT正常)(n = 74)。
1小时GIGT女性的剖宫产率较高,但非GDM组之间的出生体重无显著差异(P = 0.1978)。产后3个月时,血糖(葡萄糖曲线下面积)从正常GCT NGT组到异常GCT NGT组、到2/3小时GIGT组、到1小时GIGT组、再到GDM组逐渐升高(P < 0.0001),而胰岛素敏感性(IS(OGTT))和β细胞功能(胰岛素生成指数/胰岛素抵抗稳态模型评估[HOMA-IR])均逐渐降低(分别为P = 0.002和P < 0.0001)。胰岛素生成指数/HOMA-IR最强的独立负性预测因素是GDM(t = -4.1,P < 0.0001)和1小时GIGT(t = -3.8,P = 0.0002)。
与GDM一样,1小时GIGT与产后血糖、胰岛素抵抗和β细胞功能障碍有关。